Kenvue Inc. (NYSE:KVUE) Shares Purchased by Cohen Capital Management Inc.

Cohen Capital Management Inc. lifted its position in Kenvue Inc. (NYSE:KVUE) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 105,333 shares of the company’s stock after purchasing an additional 2,242 shares during the quarter. Cohen Capital Management Inc.’s holdings in Kenvue were worth $2,260,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in KVUE. Stephens Inc. AR lifted its position in Kenvue by 86.1% during the 4th quarter. Stephens Inc. AR now owns 57,694 shares of the company’s stock worth $1,242,000 after acquiring an additional 26,700 shares during the period. Stifel Financial Corp lifted its position in Kenvue by 60.4% during the 4th quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock worth $16,041,000 after acquiring an additional 280,591 shares during the period. Raleigh Capital Management Inc. lifted its position in Kenvue by 93,834.8% during the 4th quarter. Raleigh Capital Management Inc. now owns 43,210 shares of the company’s stock worth $930,000 after acquiring an additional 43,164 shares during the period. Fifth Third Bancorp lifted its position in Kenvue by 35.3% during the 4th quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock worth $5,976,000 after acquiring an additional 72,435 shares during the period. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Kenvue by 2.6% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock worth $34,417,000 after buying an additional 40,995 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Sanford C. Bernstein assumed coverage on Kenvue in a research note on Thursday, April 11th. They set an “underperform” rating and a $18.00 target price for the company. Citigroup cut their target price on Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research note on Wednesday. William Blair assumed coverage on Kenvue in a research note on Wednesday, April 3rd. They set a “market perform” rating for the company. Finally, HSBC increased their target price on Kenvue from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Wednesday, May 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $23.00.

Kenvue Price Performance

Kenvue stock traded up $0.22 during mid-day trading on Thursday, hitting $17.92. 35,763,785 shares of the company were exchanged, compared to its average volume of 19,496,018. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.99 and a quick ratio of 0.68. The business’s 50 day simple moving average is $19.02 and its two-hundred day simple moving average is $19.80. The company has a market capitalization of $34.31 billion, a P/E ratio of 22.97, a PEG ratio of 1.93 and a beta of 1.40. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $25.61.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.03. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. The business’s revenue was down 24.9% compared to the same quarter last year. Analysts forecast that Kenvue Inc. will post 1.17 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.46%. The ex-dividend date of this dividend was Tuesday, May 7th. Kenvue’s dividend payout ratio is currently 102.56%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.